INTRODUCTION
The field of psychopharmacology is rapidly expanding. It is challenging the traditional concepts of psychiatric treatment and research and is constantly seeking new and improved drugs to treat psychiatric disorders. In this way, psychiatrists are continuously exposed to newly introduced drugs that are claimed to be safe and more efficacious. bipolar disorder. More than 30 different antipsychotic drugs are available for clinical use. These can be divided into two groups those drugs that were originally developed (eg:chlorpromazine, haloperidol), often referred to as firstgeneration, typical or conventional antipsychotic drugs,and most recently developed agents(eg: clozapine, risperidone),which are termed atypical antipsychotic drugs. 2 The treatment of choice of schizophrenia for the past 40 years is antipsychotic monotherapy. 3 In the earlier days conventional antipsychotics were used. But with the advent of the second generation antipsychotics which are more efficacious and with better tolerability, they have become the first line drugs for the treatment of schizophrenia. 4, 5 However the cost of second generation antipsychotics have been 10 times more than those of first generation antipsychotics. 6 These cost differences is the main contributor to relatively low prescription rates of second generation antipsychotics in developing countries. 7 Many other factors have also influenced the prescription patterns like clinicians/patient preferences, traditional medicines, socioeconomic factors or cultural underpinnings. 8 Drug utilization study has been defined by the World Health Organization (WHO) as The marketing, distribution, prescription and uses of drugs in a society with special emphasis on the resulting medical, social and economical consequence. 1 The principal aim of the drug utilization research is to facilitate the rational use of the drugs. Rational drug prescribing is the use of the least number of drugs to obtain the best possible effect in the shortest period and at a reasonable cost. 9 Without the knowledge of how the drugs are being prescribed, it is difficult to suggest the measures to improve prescribing habits. This study is to analyze the drug utilization pattern in patients with schizophrenia admitted to psychiatry inpatient department of Government Medical College Kottayam, Kerala, India.
METHODS
A descriptive study was conducted in the inpatient department of Psychiatry of Government Medical College, Kottayam, Kerala, India after approval from the Institutional Ethics Committee. The study was conducted over a period of 12 months from March 2016 to February 2017. Based on the data obtained from a similar study conducted in India, sample size was calculated to be 230. 10 Informed consent was obtained from the patients legally acceptable representative. The study population included patients in all the age groups and both the sexes. All patients diagnosed by psychiatrists as schizophrenia and on antipsychotics were recruited for the study till the sample size was reached. Data was collected from the patient's case sheets using a structured proforma. Demographic details of the patient and details of the all the drugs prescribed like dose, route, and frequency of administration were recorded in the proforma. The duration of hospital stay was also noted. The total drug cost during their present hospital stay was calculated by adding the cost spent on drugs each day from the day of admission to the day of discharge with the help of price list obtained from the hospital pharmacy. All data were entered in MS Excel. Descriptive analysis was done using SPSS 16 software. Qualitative variables were expressed as frequencies and percentages. Quantitative variables were expressed as mean +/-standard deviation. Data were also analysed using WHO prescribing indicators 
RESULTS
The study analysed prescription pattern of 230 schizophrenic patients who were on antipsychotics. Among these 150 (65%) patients were males and 80 (35%) were females. Mean age was 34.8 (SD=12.19) years. Youngest patient was 14 years and eldest one was 68 years. Maximum number of patients (n=76, 33%) were in the age group 20-30 years. Table1 shows the age-gender distribution. Among the patients who received multiple antipsychotics maximum number (n=92 ,40%) of patients were given 2 antipsychotics. 3,4 and 5 antipsychotics were prescribed for 55 (24%),11 (5%) and 6 (2%) patients respectively.116 (50.4%) patients received parenteral drugs. 114(49.6%) patients received oral drugs exclusively. Most frequently prescribed parenteral preparations were of promethazine (n=86, 36.1%) and haloperidol (n=85, 35.3%) followed by fluphenazine (n=49, 20.6%), lorazepam (n=14, 5.9%) and olanzepine (n=4, 1.7%). Trihexyphenidyl (n=132, 27.9%) was the drug which was coprescribed most frequently with antipsychotics. The pattern of prescription of concomitant drugs is as shown in the Figure 3 .
Majority (n= 85, 37.4%) of the patients stayed 1-2 weeks in the hospital. Number of patients stayed less than a week was 40(17.4%) and more than 4 weeks was 42(18.3%). It was found that, for majority (n=71, 30.9%) of the schizophrenic patients, drug cost was less than Rs.25 during the hospital stay. Figure 4 shows the drug cost during the hospital stay.
DISCUSSION
This study gives information regarding prescription pattern of antipsychotics. It also determines the pattern of utilisation of drugs based on WHO prescribing indicators. This study shows a gender preponderance of schizophrenia to male patients and age preponderance to young adults (20-30 years) which is comparable to the findings of other similar studies. 10, 13 Almost all of the recent prescription pattern studies of antipsychotics concluded that, atypical antipsychotics are most frequently prescribed than typical antipsychotics due to their ability to cause low incidence of extrapyramidal side effects and better control of symptoms. 5, 6, 10 This is consistent with present study in which atypical antipsychotics were prescribed more than typical ones. In present study haloperidol (22.9%) was the most frequently prescribed antipsychotic followed by Olanzepine (20.9%), Resperidone (18%) Clozapine (12.7%), Fluphenazine (9%), Chlorpromazine (8.2%), Trifluperazine (7.4%), Quetiapine (2%) and Aripiprazole (1.6%). In a similar Indian study conducted by Iliaz et al. in 2013-2014, most commonly prescribed antipsychotic was Resperidone (40.8%) followed by Quetiapine (8.62%), Olanzapine (4.02%), Amisulpride (4.02%), Aripiprazole (0.57%). 5 In present study majority (71.3%) of the patients received multiple antipsychotics during their hospital stay amongst which most of the patients were treated with 2 antipsychotics and rest with 3,4 and 5 antipsychotics in decreasing order of frequency. These patients either received them concomitantly or switched from one to another depending upon the clinical response. The dose of the antipsychotics were cross titrated gradually when they were to be given concomitantly or if there was switching over from one antipsychotic to another. Rest of the patients (28.7%) were received single drug. Most frequently given monotherapy was olanzepine (39.4%) followed by resperidone (27.3%), haloperidol (15.2%), clozapine (7.6%), aripiprazole (6.1%), quetiapine (4.5%). Concomitant drug like trihexyphenidyl served the purpose of reducing the extrapyramidal side effects of antipsychotics by its anticholinergic antiparkinsonian action. Rest of the concomitant drugs were to impart a sedative effect on agitated patients and to stabilize their mood. Findings from a similar study done in Korea by Kim et al. shows that unlike in our study, majority (79.7%) of patients were treated with a single antipsychotic drug, while 19.2% were prescribed two antipsychotic drugs and 1.2% were prescribed three antipsychotic drugs. Of the total patients receiving monotherapy only 6.9% were prescribed a typical antipsychotic, while 93.1% were prescribed an atypical antipsychotic. The most frequently prescribed antipsychotic medications in the monotherapy group were risperidone 47.2%, olanzepine 14.5%, aripiprazole 11.4%. 14 Average number of drugs per prescription is an important index of prescription audit. 15 It helps us to measure the degree of polypharmacy. 16, 17 In the present study, the average number of drugs per prescription is four. Large proportion (73.4%) of the drugs were prescribed in their generic name. Percentage of encounters with an injection prescribed, helps to measure the overall level of use of two important, but commonly overused and costly forms of drug therapy. 18, 19 Almost half of the evaluated schizophrenic patients received injections. Of the injections, most commonly prescribed were that of promethazine and haloperidol. Utilization of drugs from Essential Drug List (WHO-19th edition) was 44.4%. In a pharmacoepidemiological study of antipsychotics conducted by Lahon K et al. derived conclusions that average number of drugs per prescription was 2.19, percentage of antipsychotic drugs prescribed by generic name was 63.64%, percentage of encounters with an injection prescribed was 3.03%, percentage of drugs prescribed from WHO essential medicines list was 3.03%. 20 In order to rationalise the drug use, it is important to determine the cost analysis. 21, 22 Average drug cost per encounter was determined by dividing total costs of all drugs prescribed by the number of encounters surveyed which was Rs. 45.43. Hence in a government setup treatment of schizophrenia is not much a financial burden for the patient's family. 8.44% of the total drug cost was spent on injections. In a drug utilization study conducted by Thakkar KB et al. among outpatients, the average cost per prescription was Rs.178 or 3.2 USD.
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CONCLUSION
Newer antipsychotics were slightly more preferred than the conventional antipsychotics. Olanzapine and haloperidol were the most frequently prescribed newer and conventional antipsychotic drugs respectively. Polytherapy was more common when compared to monotherapy in treatment of Schizophrenia. Average drug cost per encounter was Rs.45.43 which was affordable in a government setup. Limitations of this study were patients' follow up was not done. Patient compliance, adverse drug reactions and adherence to standard treatment guidelines could not be assessed. Drug utilization was not evaluated by means of drug utilization matrices like Defined Daily Dose (DDD) or Prescribed Daily Dose (PDD). Only inpatients were included in this study. Limited availability of drugs in hospital pharmacy, limitations in man-power and infrastructure leading to higher use of parenterals are also the limiting factors of this study
